DE BERNARDI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 5.829
AS - Asia 4.154
EU - Europa 2.894
SA - Sud America 448
AF - Africa 50
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.398
Nazione #
US - Stati Uniti d'America 5.681
SG - Singapore 1.384
VN - Vietnam 1.191
IT - Italia 778
CN - Cina 727
HK - Hong Kong 503
RU - Federazione Russa 473
BR - Brasile 379
DE - Germania 367
SE - Svezia 249
IE - Irlanda 243
UA - Ucraina 166
GB - Regno Unito 163
CA - Canada 107
AT - Austria 88
FI - Finlandia 76
FR - Francia 73
IN - India 67
KR - Corea 49
TR - Turchia 44
CH - Svizzera 40
ID - Indonesia 38
PL - Polonia 37
BD - Bangladesh 31
NL - Olanda 31
DK - Danimarca 30
JP - Giappone 30
AR - Argentina 29
ZA - Sudafrica 26
ES - Italia 24
MX - Messico 20
AU - Australia 15
IQ - Iraq 14
BE - Belgio 13
CO - Colombia 10
CZ - Repubblica Ceca 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
EC - Ecuador 9
BG - Bulgaria 8
MA - Marocco 7
TW - Taiwan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
LT - Lituania 6
PK - Pakistan 6
DZ - Algeria 5
JO - Giordania 5
NP - Nepal 5
DO - Repubblica Dominicana 4
RO - Romania 4
BO - Bolivia 3
BY - Bielorussia 3
EU - Europa 3
IL - Israele 3
IR - Iran 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
PE - Perù 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
Totale 13.394
Città #
Ann Arbor 946
Singapore 645
Woodbridge 505
Ashburn 492
Hong Kong 492
Fairfield 384
Hanoi 351
Ho Chi Minh City 349
Houston 335
Chandler 326
Frankfurt am Main 247
Dublin 236
Milan 225
Wilmington 220
Jacksonville 178
Dearborn 152
New York 148
Cambridge 147
Seattle 139
Santa Clara 135
Beijing 123
Dallas 104
Princeton 100
Hefei 98
Los Angeles 98
Nanjing 67
Vienna 63
Moscow 51
The Dalles 47
Chicago 46
Shanghai 44
Munich 42
Seoul 42
Lawrence 41
São Paulo 40
Altamura 36
Da Nang 35
Haiphong 34
London 33
Buffalo 32
Lachine 32
San Diego 32
Ottawa 31
Fremont 30
Quận Bình Thạnh 30
Council Bluffs 29
Boardman 28
Jakarta 27
Guangzhou 26
Warsaw 26
Hải Dương 25
Rome 25
Thái Nguyên 25
Dong Ket 24
Monza 24
Biên Hòa 22
Nanchang 22
Lissone 21
Tokyo 21
Nuremberg 20
Brooklyn 19
Quận Một 19
Stockholm 19
Amsterdam 17
Toronto 17
Can Tho 16
Changsha 16
Denver 16
Ha Long 15
Ravenna 15
San Jose 15
Chennai 14
Helsinki 14
Salt Lake City 14
Tianjin 14
Washington 14
Brussels 13
Johannesburg 13
Ninh Bình 13
Poplar 13
Vũng Tàu 13
San Francisco 12
Turku 12
Lang Son 11
Montreal 11
Naples 11
Andover 10
Atlanta 10
Boston 10
Erlenbach 10
Hebei 10
Jiaxing 10
Lappeenranta 10
Orem 10
Quận Năm 10
Shenyang 10
Jinan 9
Phủ Lý 9
Rio de Janeiro 9
Tashkent 9
Totale 8.860
Nome #
Implication of tumor morphology and MRI characteristics on the accuracy of automated versus human segmentation of GBM areas 1.225
PET textural features stability and pattern discrimination power for radiomics analysis: An “ad-hoc” phantoms study 470
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 419
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 396
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 389
Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211 315
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 298
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 272
Metodi di segmentazione avanzata: applicazioni in oncologia 268
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 262
PET quantification: strategies for partial volume correction 257
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 250
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 244
Performances of Principal Component Analysis for the extraction of respiratory signal from Time-of-Flight PET coincidences stream 236
Reconstruction of uptake patterns in PET: The influence of regularizing prior 228
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 218
Motion-Tracking Hardware and Advanced Applications in PET and PET/CT 216
A Dedicated Tomographic Image Reconstruction Algorithm for Integration-Mode Detector Configuration in Ion Imaging 212
Radiomics in PI-RADS 3 Multiparametric MRI for Prostate Cancer Identification: Literature Models Re-Implementation and Proposal of a Clinical–Radiological Model 208
Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach 208
Quantitative performance of iterative algorithms, with and without PSF and TOF, in the conditions of a dynamic cardiac 13N-ammonia study 208
Analysis of different detector and electronics defects on F18-FDG images 207
4D ML reconstruction as a tool for volumetric PET-based treatment verification in ion beam radiotherapy 205
Technical Note: A new zeolite PET phantom to test segmentation algorithms on heterogeneous activity distributions featured with ground-truth contours 202
Development of a software platform for evaluating automatic PET segmentation methods 201
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 197
Towards the Definition of Radiomic Features and Clinical Indices to Enhance the Diagnosis of Clinically Significant Cancers in PI-RADS 4 and 5 Lesions 195
Lesion quantification in oncological positron emission tomography: A maximum likelihood partial volume correction strategy 195
The use of zeolites to generate PET phantoms for the validation of quantification strategies in oncology 193
Proposal of a 4D ML Reconstruction Strategy for PET-based Treatment Verification in Ion Beam Radiotherapy 190
Joint Segmentation and Quantification of Oncological Lesions in PET/CT: Preliminary Evaluation on a Zeolite Phantom 189
Resolution recovery in PET during AWOSEM reconstruction: a performance evaluation study 188
Radiomics and liver: Where we are and where we are headed? 187
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 187
GMM guided automated level set algorithm for PET image segmentation 186
Optimized Bayes variational regularization prior for 3D PET images 184
ML segmentation strategies for object interference compensation in FDG-PET lesion quantification 183
Artificial intelligence for precision medicine in autoimmune liver disease 179
Background based Gaussian mixture model lesion segmentation in PET 177
Time of flight increases noise in MLEM PET reconstructions stopped early: Theory, simulations and phantoms 176
Geometrical interpretation of TOF PET raw data in commercial PET-CT scanner for SNR optimization 174
Towards a standard for the evaluation of PET Auto-Segmentation methods: requirements and implementation 174
Evaluation of a 2D UNet-Based Attenuation Correction Methodology for PET/MR Brain Studies 172
First clinical investigation of a 4D maximum likelihood reconstruction for 4D PET-based treatment verification in ion beam therapy 168
A simple contrast matching rule for osem reconstructed pet images with different time of flight resolution 166
Optimization of rapid acquisition with relaxation enhancement (RARE) pulse sequence parameters for 19F-MRI studies 162
Clinical investigations of a 4D ML reconstruction strategy for PET-based treatment verification in ion beam therapy 160
Iterative joint segmentation and quantification of oncological lesions in PET-CT 157
Model based lesion segmentation in FDG-PET from raw data and clinical images 157
Tuning of a 4D ML reconstruction strategy for treatment verification in ion beam radiotherapy 153
Evaluation of frequency-distance relation validity for FORE optimization in 3D PET 150
Protocol assessment for quantitative 19F MRI of low concentrated compounds on a preclinical 7T MRI scanner: preliminary evaluations and results 149
Design of a Benchmark Platform for Evaluating PET-based Contouring Accuracy in Oncology Applications 148
PET-CT scanner characterization for PET raw data use in biomedical research 145
Regularized ML reconstruction for time/dose reduction in 18F-fluoride PET/CT studies 143
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 142
Regional MLEM reconstruction strategy for PET-based treatment verification in ion beam radiotherapy 139
PET-based dosimetry in particle therapy: assessing the feasibility of regional MLEM reconstruction as a quantification tool 133
Assessment of zeolites for lesion simulation in PET-CT 128
Non-invasive imaging biomarkers in chronic liver disease 125
“Under the hood”: artificial intelligence in personalized radiotherapy 109
High Field 19F MRI: optimization of Rapid Acquisition with Relaxation Enhancement (RARE) sequences to improve the sensitivity on a preclinical 7T MRI scanner 107
Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study 56
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 29
Totale 13.766
Categoria #
all - tutte 43.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 0 113 127 103 95 83 106
2021/2022659 53 75 82 30 29 36 38 70 25 47 65 109
2022/20231.234 119 319 132 114 96 184 18 74 89 29 31 29
2023/20241.031 45 54 30 71 119 203 157 27 104 36 28 157
2024/20253.660 114 265 134 118 178 110 204 108 214 366 385 1.464
2025/20263.041 525 453 457 593 670 305 38 0 0 0 0 0
Totale 13.766